UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3786-3791

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study

International journal of radiation oncology, biology, physics, 2006-05, Vol.65 (1), p.169-176

2006

Link zum Volltext

Verfügbarkeit prüfen

HIPEC after neoadjuvant chemotherapy is associated with acceptable toxicity and favorable quality of life in newly diagnosed advanced ovarian cancer patients

Gynecologic oncology, 2022-11, Vol.167 (2), p.234-238

2022

Link zum Volltext

Verfügbarkeit prüfen

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173

Gynecologic oncology, 2013-02, Vol.128 (2), p.155-159

2013

Link zum Volltext

Verfügbarkeit prüfen

Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway

Cancers, 2022-10, Vol.14 (20), p.5099

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic oncology, 2011-07, Vol.122 (1), p.111-115

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

Gynecologic oncology, 2004, Vol.92 (1), p.10-14

2004

Link zum Volltext

Verfügbarkeit prüfen

Transvaginal ureteroneocystostomy

Urology case reports, 2023-11, Vol.51, p.102558, Article 102558

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum Calcium and Serum Albumin Are Biomarkers That Can Discriminate Malignant from Benign Pelvic Masses

Cancer epidemiology, biomarkers & prevention, 2015-10, Vol.24 (10), p.1593-1598

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

Gynecologic oncology, 2004, Vol.92 (1), p.4-9

2004

Link zum Volltext

Verfügbarkeit prüfen

Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms

The American journal of surgery, 2011-10, Vol.202 (4), p.481-486

2011

Link zum Volltext

Verfügbarkeit prüfen

Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study

International journal of gynecological cancer, 2014-11, Vol.24 (9), p.1583-1589

2014

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study

Gynecologic oncology, 2005-03, Vol.96 (3), p.630-634

2005

Link zum Volltext

Verfügbarkeit prüfen

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Gynecologic oncology, 2000-11, Vol.79 (2), p.147-153

2000

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2003-10, Vol.21 (20), p.3808-3813

2003

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study

Gynecologic oncology, 2003-04, Vol.89 (1), p.95-98

2003

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

Gynecologic oncology, 2011-03, Vol.120 (3), p.454-458

2011

Link zum Volltext

Verfügbarkeit prüfen

Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study

International journal of radiation oncology, biology, physics, 2000-11, Vol.48 (4), p.1007-1013

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2000-01, Vol.18 (1), p.106-115

2000

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal hyperthermic chemotherapy using carboplatin: A phase I analysis in ovarian carcinoma

Gynecologic oncology, 2007-07, Vol.106 (1), p.207-210

2007

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Gynecologic oncology, 2002-12, Vol.87 (3), p.247-251

2002

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Carcinoma Diagnosed by Positron Emission Tomography: A Case Report

Gynecologic oncology, 2002-08, Vol.86 (2), p.223-224

Lentz, Samuel S.

2002

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group

Gynecologic oncology, 2004-12, Vol.95 (3), p.496-499

2004

Link zum Volltext

Verfügbarkeit prüfen

Topotecan Has Substantial Antitumor Activity as First-Line Salvage Therapy in Platinum-Sensitive Epithelial Ovarian Carcinoma: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2000-03, Vol.18 (5), p.1062-1067

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(116)
Japanisch
(6)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Life Sciences & Biomedicine
(75)
Humans
(68)
Female
(64)
Middle Aged
(43)
Oncology
(42)
Aged
(39)
Biological And Medical Sciences
(37)
Medical Sciences
(37)
Adult
(34)
Obstetrics & Gynecology
(31)
Chemotherapy
(21)
Pharmacology. Drug Treatments
(17)
Ovarian Neoplasms - Drug Therapy
(16)
Antineoplastic Agents
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Gynecology. Andrology. Obstetrics
(15)
Tumors
(15)
Aged, 80 And Over
(14)
Male
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A Gynecologic Oncology Group Study

A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group study

HIPEC after neoadjuvant chemotherapy is associated with acceptable toxicity and favorable quality of life in newly diagnosed advanced ovarian cancer patients

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173

Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

Transvaginal ureteroneocystostomy

Serum Calcium and Serum Albumin Are Biomarkers That Can Discriminate Malignant from Benign Pelvic Masses

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms

Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study

Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study

Intraperitoneal hyperthermic chemotherapy using carboplatin: A phase I analysis in ovarian carcinoma

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Endometrial Carcinoma Diagnosed by Positron Emission Tomography: A Case Report

Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group

Topotecan Has Substantial Antitumor Activity as First-Line Salvage Therapy in Platinum-Sensitive Epithelial Ovarian Carcinoma: A Gynecologic Oncology Group Study

Suchergebnisse filtern